Cabaletta Bio Inc expected to post a loss of 45 cents a share - Earnings Preview

Cabaletta Bio

13/03/2023 14:29

* Cabaletta Bio Inc  CABA.OQ   CABA.O  is expected to show
no
change in quarterly revenue when it reports  results on March 15
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Cabaletta Bio Inc
is for
a loss of 45 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cabaletta
Bio Inc
is $13​, above​ its last closing price of $7.08. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.47       -0.48      -0.39     Beat    19
 Jun. 30 2022  -0.50       -0.50      -0.45     Beat    10.9
 Mar. 31 2022  -0.56       -0.60      -0.45     Beat    24.5​
 Dec. 31 2021  -0.64       -0.60      -0.49     Beat    19
 ​​Sep.        -0.48       -0.50      -0.45     Beat    10.4
 30 2021                                                
 Jun. 30 2021  -0.47       -0.50      -0.45     Beat    10.5​
 Mar. 31 2021  -0.45       -0.46      -0.41     Beat    10.9
 Dec. 31 2020  -0.37       -0.36      -0.40     Missed  -10.3
 This summary was machine generated March 13 at 14:29 GMT.  All
figures in US dollars  unless otherwise stated